Middle Eastern Patients with Breast Cancer and Depression: A Systematic Review and Meta-Analysis

IF 0.5 Q4 PSYCHIATRY

Iranian Journal of Psychiatry and Behavioral Sciences Pub Date : 2023-09-14 DOI:10.5812/ijpbs-135463

Sima Rafiei, Fatemeh Pashazadeh Kan, Samira Raoofi, Akbar Javan Biparva, Ahmad Ghashghaee

{"title":"Middle Eastern Patients with Breast Cancer and Depression: A Systematic Review and Meta-Analysis","authors":"Sima Rafiei, Fatemeh Pashazadeh Kan, Samira Raoofi, Akbar Javan Biparva, Ahmad Ghashghaee","doi":"10.5812/ijpbs-135463","DOIUrl":null,"url":null,"abstract":"Context: Breast cancer (BC) is the most prevalent cancer diagnosed in women and the second most common cancer worldwide. Objectives: This study aimed to determine the rates of depression and identify the characteristics that put women at risk for developing depression while coping with BC in the Middle East. Evidence Acquisition: The present meta-analysis was performed by searching for keywords related to BC and depression in Middle East countries, including Egypt, Iran, Jordan, Lebanon, Pakistan, Qatar, and Turkey, in 4 main databases (PubMed, Embase, Web of Science, and Scopus) between January 2000 and November 2021. The results were analyzed using R and CMA software. Results: Fifteen English-language papers were included in this meta-analysis. The estimated prevalence of depression was 40.8% among a total of 2369 BC women, with the highest depression rate (83.9%) among Pakistani women (95% CI, 73.6 - 89.5; P = 0.000) and the lowest depression rate (27.5%) among Turkish women (95% CI, 17.2 - 40.9; P = 0.002). The women who were under treatment had higher levels of depression compared with those who were treated. Conclusions: The diagnosis of depression during a clinical treatment process can provide accurate assessments of the mental and social well-being of patients and consequently inform them about their own care. Thus, cancer treatment centers need to integrate mental illness assessment and support significant parts of the treatment plan to prevent and treat depression among BC patients.","PeriodicalId":46644,"journal":{"name":"Iranian Journal of Psychiatry and Behavioral Sciences","volume":"30 1","pages":"0"},"PeriodicalIF":0.5000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Psychiatry and Behavioral Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/ijpbs-135463","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Context: Breast cancer (BC) is the most prevalent cancer diagnosed in women and the second most common cancer worldwide. Objectives: This study aimed to determine the rates of depression and identify the characteristics that put women at risk for developing depression while coping with BC in the Middle East. Evidence Acquisition: The present meta-analysis was performed by searching for keywords related to BC and depression in Middle East countries, including Egypt, Iran, Jordan, Lebanon, Pakistan, Qatar, and Turkey, in 4 main databases (PubMed, Embase, Web of Science, and Scopus) between January 2000 and November 2021. The results were analyzed using R and CMA software. Results: Fifteen English-language papers were included in this meta-analysis. The estimated prevalence of depression was 40.8% among a total of 2369 BC women, with the highest depression rate (83.9%) among Pakistani women (95% CI, 73.6 - 89.5; P = 0.000) and the lowest depression rate (27.5%) among Turkish women (95% CI, 17.2 - 40.9; P = 0.002). The women who were under treatment had higher levels of depression compared with those who were treated. Conclusions: The diagnosis of depression during a clinical treatment process can provide accurate assessments of the mental and social well-being of patients and consequently inform them about their own care. Thus, cancer treatment centers need to integrate mental illness assessment and support significant parts of the treatment plan to prevent and treat depression among BC patients.

查看原文本刊更多论文

中东乳腺癌患者和抑郁症:系统回顾和荟萃分析

背景:乳腺癌(BC)是女性中最常见的癌症，也是世界上第二常见的癌症。目的:本研究旨在确定抑郁症的发生率，并确定中东地区女性在应对BC时患抑郁症的风险特征。证据获取:本荟萃分析是通过在2000年1月至2021年11月期间的4个主要数据库(PubMed、Embase、Web of Science和Scopus)中搜索中东国家(包括埃及、伊朗、约旦、黎巴嫩、巴基斯坦、卡塔尔和土耳其)中与BC和抑郁症相关的关键词进行的。采用R和CMA软件对结果进行分析。结果:本meta分析纳入了15篇英文论文。在总共2369名公元前妇女中，抑郁症的估计患病率为40.8%，其中巴基斯坦妇女的抑郁率最高(83.9%)(95% CI, 73.6 - 89.5;P = 0.000)，土耳其妇女的抑郁率最低(27.5%)(95% CI, 17.2 - 40.9;P = 0.002)。与接受治疗的女性相比，接受治疗的女性抑郁程度更高。结论:在临床治疗过程中对抑郁症的诊断可以准确评估患者的心理和社会健康状况，从而告知患者自己的护理。因此，癌症治疗中心需要整合精神疾病评估，并支持治疗计划的重要部分，以预防和治疗BC患者的抑郁症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Iranian Journal of Psychiatry and Behavioral Sciences PSYCHIATRY-

CiteScore

1.20

自引率

10.00%

发文量

期刊介绍： The Iranian Journal of Psychiatry and Behavioral Sciences (IJPBS) is an international quarterly peer-reviewed journal which is aimed at promoting communication among researchers worldwide and welcomes contributions from authors in all areas of psychiatry, psychology, and behavioral sciences. The journal publishes original contributions that have not previously been submitted for publication elsewhere. Manuscripts are received with the understanding that they are submitted solely to the IJPBS. Upon submission, they become the property of the Publisher and that the data in the manuscript have been reviewed by all authors, who agree to the analysis of the data and the conclusions reached in the manuscript. The Publisher reserves copyright and renewal on all published material and such material may not be reproduced without the written permission of the Publisher. Statements in articles are the responsibility of the authors.